Technology Licensing Opportunity: Plagueguard Antibodies

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 118475009

  Document Type - Tender Notices

Description - Description: Los Alamos National Laboratory scientists have developed high-affinity human antibodies that can quickly detect and potentially treat deadly, antibiotic-resistant plague infections, helping protect against both natural outbreaks and biot error threats. The Challenge: Plague, caused by the bacterium Yersinia pestis, remains a serious threat—not just as a rare but deadly natural infection, but also as a potential bioweapon. Modern medicine relies heavily on antibiotics, but these can fail if the bacteria become resistant, which is a growing global concern. Rapid, accurate detection is also difficult, and existing diagnostic tools can produce false results or aren't practical for

Gt Ref Id - 118475009

Deadline - Oct 10, 2025